Scarica l'app Stockscreener
464.93
1.50%
-7.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$471.99
Aprire:
$468.7
Volume 24 ore:
393.71K
Relative Volume:
0.84
Capitalizzazione di mercato:
$20.02B
Reddito:
$3.08B
Utile/perdita netta:
$1.24B
Rapporto P/E:
18.15
EPS:
25.6108
Flusso di cassa netto:
$1.07B
1 W Prestazione:
-3.79%
1M Prestazione:
-7.01%
6M Prestazione:
+55.93%
1 anno Prestazione:
+26.89%
Intervallo 1D:
$461.45
$470.08
Intervallo di 1 settimana:
$461.45
$485.76
Portata 52W:
$266.98
$519.99
United Therapeutics Corp Stock (UTHR) Company Profile
Nome
United Therapeutics Corp
Settore
Telefono
(301) 608-9292
Indirizzo
1000 SPRING ST, SILVER SPRING, MD
Confronta UTHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Underweight |
| 2025-09-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-06-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-02-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2022-12-06 | Iniziato | UBS | Buy |
| 2022-12-05 | Iniziato | Goldman | Sell |
| 2022-10-11 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-20 | Reiterato | BofA Securities | Underperform |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-02-11 | Iniziato | BTIG Research | Neutral |
| 2021-07-14 | Aggiornamento | Argus | Hold → Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-02-01 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-06-25 | Reiterato | H.C. Wainwright | Neutral |
| 2020-03-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-27 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-01-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Iniziato | BofA/Merrill | Underperform |
| 2019-08-01 | Aggiornamento | Jefferies | Underperform → Hold |
| 2019-08-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-09 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2018-08-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Reiterato | Barclays | Underweight |
| 2018-01-18 | Ripresa | Credit Suisse | Underperform |
| 2017-12-27 | Reiterato | Wedbush | Outperform |
| 2017-04-27 | Reiterato | Wedbush | Outperform |
| 2017-03-30 | Iniziato | UBS | Sell |
| 2017-03-16 | Iniziato | Credit Suisse | Underperform |
Mostra tutto
United Therapeutics Corp Borsa (UTHR) Ultime notizie
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
Polaris Capital Management LLC Sells 5,600 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Reassessing United Therapeutics (UTHR) Valuation After Strong 1 Year Share Price Performance - Yahoo Finance
United Therapeutics’ Phase 3 Ralinepag Trial Reaches Completion, Setting Up a Key Catalyst in Pulmonary Arterial Hypertension - TipRanks
United Therapeutics Corporation $UTHR Shares Sold by State of Alaska Department of Revenue - MarketBeat
SG Americas Securities LLC Purchases 7,483 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Position Decreased by Nepsis Inc. - MarketBeat
How United Therapeutics Corporation (UTH) stock expands through international marketsTreasury Yields & Verified Swing Trading Watchlists - Улправда
Is United Therapeutics Corporation stock a good choice for value investorsJuly 2025 Recap & AI Enhanced Execution Alerts - Улправда
MannKind Provides Business Updates and 2026 Growth Drivers - Benzinga
United Therapeutics (NASDAQ:UTHR) COO Sells $7,127,932.50 in Stock - MarketBeat
Director Jan Malcolm Sells Shares of United Therapeutics Corp - GuruFocus
United Therapeutics (UTHR): UBS Raises Price Target, Maintains B - GuruFocus
Is United Therapeutics Corporation's (NASDAQ:UTHR) Recent Performance Tethered To Its Attractive Financial Prospects? - Yahoo Finance
United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares - MarketBeat
United Therapeutics Corporation (UTHR) Stock Analysis: A Healthcare Giant with Strong Growth Potential and Robust Analyst Support - DirectorsTalk Interviews
Biotech developing organ transplant tech steps onto J.P. Morgan stage - Stock Titan
United Therapeutics Corporation $UTHR Shares Bought by Merit Financial Group LLC - MarketBeat
Allspring Global Investments Holdings LLC Acquires 4,944 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares - MarketBeat
United Therapeutics Corporation $UTHR Position Increased by Cwm LLC - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 137,900 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance
United Therapeutics (NASDAQ:UTHR) COO Michael Benkowitz Sells 22,500 Shares - MarketBeat
United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView — Track All Markets
United Therapeutics president sells $3.5m in stock - MSN
United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing - marketscreener.com
Death Cross: Can United Therapeutics Corporation stock sustain market leadershipTrend Reversal & AI Based Buy/Sell Signal Reports - moha.gov.vn
Pacer Advisors Inc. Decreases Position in United Therapeutics Corporation $UTHR - MarketBeat
S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag - 富途牛牛
S&P 500 Futures Flat in Premarket Trading; United Therapeutics, Intel Lag - Barron's
United Therapeutics (NASDAQ:UTHR) Reaches New 1-Year HighHere's What Happened - MarketBeat
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
Jan Malcolm Sells 50 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Louis Sullivan Sells 5,950 Shares - MarketBeat
United Therapeutics Director Malcolm Jan Sells Shares - TradingView — Track All Markets
Voya Investment Management LLC Lowers Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Wedge Capital Management L L P NC Reduces Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR): Revisiting Valuation After Xenotransplantation Progress and Strong Financial Performance - simplywall.st
Will United Therapeutics Corporation (UTH) stock see valuation expansionJuly 2025 Earnings & Safe Capital Allocation Plans - Улправда
VIX Spike: Will United Therapeutics Corporation (UTH) stock see valuation expansionQuarterly Investment Review & Growth-Oriented Investment Plans - Улправда
Chmn Rothblatt Files To Sell 2,000 Of United Therapeutics Corp [UTHR] - TradingView — Track All Markets
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 2,000 Shares - MarketBeat
United Therapeutics Executives Engage in Stock Transactions - TradingView — Track All Markets
Published on: 2025-12-19 23:14:09 - Улправда
United Therapeutics stock hits all-time high at 514.05 USD - Investing.com
United Therapeutics stock hits all-time high at 514.05 USD By Investing.com - Investing.com Canada
How resilient is United Therapeutics Corporation stock in market downturnsJuly 2025 Gainers & Free Community Consensus Stock Picks - Улправда
Why United Therapeutics Corporation stock could see breakout soonJuly 2025 Levels & Daily Chart Pattern Signal Reports - DonanımHaber
Osaic Holdings Inc. Raises Stake in United Therapeutics Corporation $UTHR - MarketBeat
Will United Therapeutics Corporation (UTH) stock beat revenue estimatesJuly 2025 Action & Free High Accuracy Swing Entry Alerts - Улправда
United Therapeutics Corp Azioni (UTHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.16%
8.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):